Volume 78, Number 9, February 28, 2012
About this course
- Released: 02/27/2012
- Expires: 02/28/2014
Learning Objectives:
Upon completion of the article by Flemming et al, the participant should be able to:
• Recognize the importance of understanding the natural history of intracerebral cavernous malformations (ICMs) in regard to accurate counseling and treatment recommendations
• List the risk factors found in this study for prospective hemorrhage in patients diagnosed with ICMs
• Discuss the findings from this study regarding time since initial ICM hemorrhage and subsequent hemorrhage rate
Core Competencies:
The article by Flemming et al covers the following core competency:
• Medical Knowledge
Learning Objectives:
Upon completion of the article by Yamashita et al, the participant should be able to:
• Discuss the pathophysiology and inheritance pattern of familial amyloid polyneuropathy (FAP)
• Discuss the mechanism underlying the historical use of liver transplantation for FAP
• State the results from this study comparing the long-term survival in patients with FAP who received liver transplantation versus those who did not
Core Competencies:
The article by Yamashita et al covers the following core competency:
• Medical Knowledge
Author Disclosures
Refer to Information and Author section available in the Tool Bar for each article.
THIS PAGE IS REQUIRED READING BEFORE BEGINNING ALL ACCME-ACCREDITED COURSES
ACCREDITATION STATEMENT
The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed. Physicians should only claim credit commensurate with the extent of their participation in the activity. The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
MISSION STATEMENT/PROGRAM OBJECTIVES
After evaluating a specific article published in Neurology, participants in the CME activity should be able to demonstrate an increase in, or affirmation of, their knowledge of clinical medicine. Participants should be able to evaluate the appropriateness of the clinical information as it applies to the provision of patient care.
PARTICIPANTS
This program is designed for physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine.
CREDITS
The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed.
The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.
DISCLOSURES
Steven Lewis, MD, has received personal compensation in an editorial capacity for the National Board of Medical Examiners and the American College of Physicians; Paul Schulz, MD, has received personal compensation for activities with Pfizer.
COMMERCIAL SUPPORT
This CME program receives no commercial support.
